Related Experiment Video

Updated: Aug 29, 2026

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
09:26

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

Antibiotics in asthma

David A Beuther1, Richard J Martin

  • 1Division of Pulmonary Medicine, National Jewish Medical and Research Center, 1400 Jackson Street, J206, Denver, CO 80206, USA. martinr@njc.org

Current Allergy and Asthma Reports
|February 11, 2004
PubMed

Insights

Certain bacteria may contribute to asthma development and progression. Macrolide antibiotics show anti-inflammatory effects beyond eradicating these microbes, potentially aiding asthma management.

Area of Science:

  • Pulmonology
  • Microbiology
  • Pharmacology

Background:

  • Asthma pathogenesis involves complex genetic and environmental factors.
  • Mycoplasma pneumoniae and Chlamydia pneumoniae are implicated in airway inflammation contributing to asthma.
  • Eradicating these organisms may alter asthma's course.

Purpose of the Study:

  • To explore the role of Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma.
  • To investigate the potential of antimicrobial therapy in managing asthma.
  • To examine the anti-inflammatory properties of macrolide antibiotics in asthma.

Main Methods:

  • Review of evidence linking specific bacterial infections to asthma.
  • Analysis of macrolide antibiotic mechanisms, including anti-inflammatory effects.
  • Discussion of potential therapeutic strategies for asthma management.

Main Results:

  • Evidence suggests Mycoplasma pneumoniae and Chlamydia pneumoniae promote airway inflammation relevant to asthma.
  • Macrolide antibiotics possess anti-inflammatory properties independent of antimicrobial activity.
  • These properties may stem from inhibiting drug metabolism and other incompletely understood mechanisms.

Conclusions:

  • Antimicrobial therapy could potentially modify asthma's clinical course by targeting specific pathogens.
  • Macrolide antibiotics demonstrate broad anti-inflammatory potential useful in asthma and other inflammatory conditions.
  • Further research is needed to fully elucidate macrolide mechanisms in inflammatory diseases.

More Related Videos

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Related Concept Videos

Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...